Your browser is no longer supported. Please, upgrade your browser.
Settings
VAR Varian Medical Systems, Inc. daily Stock Chart
VAR [NYSE]
Varian Medical Systems, Inc.
IndexS&P 500 P/E60.34 EPS (ttm)2.85 Insider Own0.10% Shs Outstand90.80M Perf Week-0.95%
Market Cap15.73B Forward P/E33.81 EPS next Y5.08 Insider Trans-49.88% Shs Float90.65M Perf Month-0.42%
Income260.80M PEG6.10 EPS next Q1.02 Inst Own95.90% Short Float4.95% Perf Quarter48.19%
Sales3.20B P/S4.92 EPS this Y-16.10% Inst Trans1.55% Short Ratio3.05 Perf Half Y58.81%
Book/sh21.29 P/B8.07 EPS next Y34.47% ROA6.10% Target Price177.64 Perf Year45.87%
Cash/sh- P/C- EPS next 5Y9.90% ROE14.20% 52W Range89.62 - 176.19 Perf YTD21.02%
Dividend- P/FCF59.12 EPS past 5Y-3.30% ROI12.10% 52W High-2.46% Beta1.16
Dividend %- Quick Ratio1.00 Sales past 5Y1.10% Gross Margin43.40% 52W Low91.77% ATR0.71
Employees10062 Current Ratio1.30 Sales Q/Q-15.90% Oper. Margin10.50% RSI (14)72.25 Volatility0.49% 0.43%
OptionableYes Debt/Eq0.31 EPS Q/Q72.10% Profit Margin8.20% Rel Volume0.90 Prev Close171.81
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout0.00% Avg Volume1.47M Price171.86
Recom2.10 SMA20-0.75% SMA505.86% SMA20027.53% Volume1,325,763 Change0.03%
Aug-11-20Downgrade BTIG Research Buy → Neutral
Aug-06-20Downgrade UBS Buy → Neutral $150 → $177.50
Aug-03-20Upgrade Evercore ISI Underperform → In-line $177.50
Aug-03-20Downgrade Piper Sandler Overweight → Neutral $142 → $177.50
Apr-01-20Downgrade Goldman Buy → Neutral $171 → $114
Feb-13-20Initiated Goldman Buy $171
Jan-30-20Reiterated Barrington Research Outperform $152 → $160
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Oct-14-19Upgrade BTIG Research Neutral → Buy $130
Mar-22-19Upgrade Robert W. Baird Neutral → Outperform $127 → $162
Jan-04-19Upgrade Goldman Neutral → Buy
Oct-19-18Resumed Robert W. Baird Neutral
Jun-28-18Resumed JP Morgan Underweight
Jan-25-18Upgrade Barrington Research Mkt Perform → Outperform $130
Jan-03-18Initiated Evercore ISI Underperform
Sep-07-17Downgrade BTIG Research Buy → Neutral
May-16-17Initiated Goldman Neutral $92
May-08-17Upgrade Citigroup Neutral → Buy
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $82 → $90
Apr-27-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-23-20 11:55PM  
Sep-22-20 09:43PM  
Sep-21-20 03:20PM  
Sep-20-20 08:00PM  
10:32AM  
Sep-19-20 10:40AM  
Sep-18-20 08:07PM  
Sep-17-20 04:31PM  
01:46PM  
Sep-16-20 02:31PM  
01:29PM  
11:50AM  
08:15AM  
Sep-15-20 07:02PM  
06:37AM  
Sep-14-20 09:00AM  
Sep-11-20 10:39AM  
Sep-10-20 08:15AM  
Sep-09-20 08:30PM  
04:24PM  
01:15PM  
Sep-08-20 06:47AM  
Sep-06-20 07:00PM  
Sep-05-20 11:10AM  
Sep-04-20 08:00PM  
Sep-03-20 03:11AM  
03:02AM  
Sep-02-20 08:00PM  
01:07PM  
11:20AM  
Sep-01-20 11:15PM  
07:41PM  
07:38PM  
09:35AM  
Aug-27-20 04:35PM  
Aug-26-20 06:39PM  
Aug-25-20 08:19AM  
Aug-24-20 06:41PM  
Aug-22-20 07:35AM  
Aug-20-20 02:03PM  
12:47PM  
Aug-18-20 04:11PM  
Aug-17-20 06:45PM  
Aug-14-20 10:35PM  
10:15AM  
02:30AM  
Aug-13-20 09:00PM  
Aug-11-20 12:00PM  
11:55AM  
Aug-10-20 10:40AM  
06:26AM  
Aug-08-20 10:15PM  
Aug-06-20 07:15PM  
06:55PM  
06:32PM  
09:27AM  
Aug-05-20 01:15PM  
08:15AM  
Aug-04-20 05:46PM  
12:07PM  
12:02PM  
Aug-03-20 10:40PM  
09:00PM  
06:36PM  
04:12PM  
04:01PM  
03:19PM  
02:40PM  
01:36PM  
01:34PM  
12:36PM  
11:50AM  
11:41AM  
11:09AM  
11:06AM  
10:26AM  
09:55AM  
08:45AM  
08:21AM  
07:28AM  
05:09AM  
03:01AM  
03:01AM  
12:08AM  
Aug-02-20 08:12PM  
11:54AM  
04:00AM  
03:55AM  
03:53AM  
Aug-01-20 08:32PM  
08:03PM  
Jul-25-20 10:15AM  
Jul-20-20 12:15PM  
Jul-17-20 05:00PM  
Jul-06-20 08:15AM  
Jul-01-20 02:15AM  
Jun-25-20 08:15AM  
Jun-15-20 09:50AM  
Jun-08-20 07:11PM  
Jun-01-20 04:15PM  
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILSON DOW RPresident and CEOSep 21Option Exercise67.1238,9072,611,438121,471Sep 23 01:15 PM
WILSON DOW RPresident and CEOSep 21Sale172.4338,9076,708,73082,564Sep 23 01:15 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOSep 14Option Exercise131.7740052,70827,518Sep 16 06:55 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOSep 14Sale173.4840069,39227,118Sep 16 06:55 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOSep 08Option Exercise112.8254361,26127,661Sep 10 05:13 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOSep 08Sale173.6054394,26627,118Sep 10 05:13 PM
WILSON DOW RPresident and CEOAug 21Option Exercise67.1238,9072,611,438121,471Aug 24 11:52 AM
WILSON DOW RPresident and CEOAug 21Sale172.6338,9076,716,33382,564Aug 24 11:52 AM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOAug 14Option Exercise131.7740052,70827,518Aug 19 11:19 AM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOAug 14Sale173.1840069,27127,118Aug 19 11:19 AM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOAug 10Option Exercise130.377,344957,42934,462Aug 12 07:33 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOAug 10Sale173.317,3441,272,76627,118Aug 12 07:33 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJul 29Option Exercise112.822,716306,41929,834Jul 31 04:33 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJul 29Sale135.002,716366,66027,118Jul 31 04:33 PM
Bruff Jesse MichaelSVP Finance, CFOMay 07Sale117.2220524,031919May 11 04:00 PM
Toth Christopher A.SVP and Pres. Oncology SystemsApr 13Sale109.741,625178,3251,624Apr 15 01:07 PM
WILSON DOW RPresident and CEOMar 17Option Exercise67.1238,9092,611,572121,267Mar 18 03:39 PM
WILSON DOW RPresident and CEOMar 17Sale110.0038,9094,279,99082,358Mar 18 03:39 PM
MOMSEN MAGNUSSVP, CAO, Corporate ControllerFeb 19Sale147.191,090160,439897Feb 21 03:10 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOFeb 19Sale147.192,653390,50327,118Feb 21 03:07 PM
Febbo Phillip G.DirectorFeb 14Option Exercise0.004740474Feb 19 07:29 PM
ECKERT R ANDREWDirectorFeb 13Option Exercise0.001,243013,098Feb 18 07:36 PM
Ashkenazi AnatDirectorFeb 13Option Exercise0.001,34901,349Feb 18 07:34 PM
Balser Jeffrey R.DirectorFeb 13Option Exercise0.001,24301,599Feb 18 07:32 PM
BRUNER JUDYDirectorFeb 13Option Exercise0.001,24305,554Feb 18 07:30 PM
BUTEL JEAN LUCDirectorFeb 13Option Exercise0.001,24302,252Feb 18 07:28 PM
DUGAN REGINA EDirectorFeb 13Option Exercise0.001,243011,171Feb 18 07:26 PM
ILLINGWORTH DAVID JDirectorFeb 13Option Exercise0.001,243014,144Feb 18 07:25 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOFeb 10Option Exercise94.561,243117,54128,361Feb 12 05:06 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOFeb 10Sale141.681,243176,11127,118Feb 12 05:06 PM
ECKERT R ANDREWDirectorFeb 04Option Exercise61.985,651350,24915,566Feb 04 07:25 PM
ECKERT R ANDREWDirectorFeb 04Sale142.415,651804,7599,915Feb 04 07:25 PM
ILLINGWORTH DAVID JDirectorFeb 03Option Exercise61.985,651350,24916,562Feb 04 07:24 PM
ILLINGWORTH DAVID JDirectorFeb 03Sale141.235,651798,09110,911Feb 04 07:24 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJan 10Option Exercise80.4069956,20027,118Jan 10 06:40 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJan 08Option Exercise112.8254361,26127,661Jan 10 06:40 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJan 08Sale146.711,242182,21426,419Jan 10 06:40 PM
Toth Christopher A.SVP and Pres. Oncology SystemsJan 03Option Exercise112.821,597180,1743,282Jan 07 06:57 PM
Toth Christopher A.SVP and Pres. Oncology SystemsJan 03Sale145.001,597231,5651,685Jan 07 06:57 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJan 02Option Exercise94.591,243117,57433,224Jan 06 07:55 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGOJan 02Sale143.286,106874,86927,118Jan 06 07:55 PM
KUO JOHN WSVP, Gen Counsel and SecretaryDec 16Option Exercise94.3081476,76039,373Dec 18 07:33 PM
KUO JOHN WSVP, Gen Counsel and SecretaryDec 16Sale141.97814115,56638,559Dec 18 07:33 PM
KUO JOHN WSVP, Gen Counsel and SecretaryDec 12Option Exercise112.822,443275,61941,002Dec 16 06:09 PM
KUO JOHN WSVP, Gen Counsel and SecretaryDec 12Sale142.002,443346,90638,559Dec 16 06:09 PM
Toth Christopher A.SVP and Pres. Oncology SystemsDec 06Sale138.9556478,3661,685Dec 10 06:22 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGONov 15Option Exercise94.574,969469,92432,087Nov 20 07:52 AM
KUO JOHN WSVP, Gen Counsel and SecretaryNov 15Option Exercise80.4046537,38635,568Nov 19 09:57 PM
KUO JOHN WSVP, Gen Counsel and SecretaryNov 15Sale128.0246559,53135,103Nov 19 09:57 PM
KENNEDY KOLLEEN TPres. Proton Solutions, CGONov 15Sale128.004,969636,03227,118Nov 20 07:52 AM
KUO JOHN WSVP, Gen Counsel and SecretaryOct 15Option Exercise80.4046537,38635,566Oct 17 06:00 PM
KUO JOHN WSVP, Gen Counsel and SecretaryOct 15Sale113.8346552,93235,101Oct 17 06:00 PM